• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

四个社区队列中肥胖与阻塞性睡眠呼吸暂停之间的关系:一项对12860名成年人的个体参与者数据荟萃分析

The relationship between obesity and obstructive sleep apnea in four community-based cohorts: an individual participant data meta-analysis of 12,860 adults.

作者信息

Esmaeili Neda, Gell Laura, Imler Théo, Hajipour Mohammadreza, Taranto-Montemurro Luigi, Messineo Ludovico, Stone Katie L, Sands Scott A, Ayas Najib, Yee John, Cronin John, Heinzer Raphael, Wellman Andrew, Redline Susan, Azarbarzin Ali

机构信息

Division of Sleep and Circadian Disorders, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.

Apnimed, USA.

出版信息

EClinicalMedicine. 2025 Apr 23;83:103221. doi: 10.1016/j.eclinm.2025.103221. eCollection 2025 May.

DOI:10.1016/j.eclinm.2025.103221
PMID:40330547
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12051718/
Abstract

BACKGROUND

Obesity is a well-established risk factor for obstructive sleep apnea (OSA). We assessed the reciprocal prevalence of obesity and OSA and how it varies by age and sex.

METHODS

Following a systematic review through March 27, 2025, the final sample included four community-based cohort studies in the US and Switzerland. OSA severity was quantified using the apnea-hypopnea index (AHI, all apneas plus hypopneas with ≥4% oxygen desaturation/hour). Random effects individual participant data (IPD) meta-analyses estimated prevalences. Logistic regression compared odds of OSA across weight groups.

FINDINGS

Among 12,860 adults (mean ± SD age: 66.6 ± 7.3 years), 7222 (56.2%) had OSA (AHI ≥5 events/h) and 3309 (25.7%) had obesity (BMI ≥30 kg/m). IPD meta-analysis showed 31.5% [95% CI: 16.8-48.5] of individuals with OSA had obesity and 44.4% [36.5-52.5] had overweight status (25 ≤ BMI < 30). Among subgroups of individuals with obesity and overweight, 74.3% [63.8-83.5] and 59.8% [46.5-75.7] had any OSA, respectively. Obesity was higher in females than males with OSA, and in younger (<65 years) vs. older individuals. Odds ratios for OSA in subgroups of individuals with overweight and obesity compared to BMI <25 kg/m were 2.18 [1.73-2.76] and 4.84 [3.09-6.00], respectively.

INTERPRETATION

Our analyses show that most adults with OSA do not have obesity, with 44.4% having overweight and 23.5% having normal weight or underweight. Obesity was more prevalent among females compared to males and in younger individuals (<65 years) compared to older individuals with OSA. Recognizing OSA is not exclusive to obesity highlights the need for personalized treatment plans.

FUNDING

American Academy of Sleep Medicine, National Heart, Lung, and Blood Institute, and Apnimed.

摘要

背景

肥胖是阻塞性睡眠呼吸暂停(OSA)公认的危险因素。我们评估了肥胖与OSA的相互患病率及其在年龄和性别上的差异。

方法

在截至2025年3月27日的系统评价之后,最终样本包括美国和瑞士的四项基于社区的队列研究。使用呼吸暂停低通气指数(AHI,所有呼吸暂停加低通气且氧饱和度下降≥4%/小时)对OSA严重程度进行量化。随机效应个体参与者数据(IPD)荟萃分析估计患病率。逻辑回归比较了不同体重组中OSA的比值比。

结果

在12860名成年人(平均±标准差年龄:66.6±7.3岁)中,7222人(56.2%)患有OSA(AHI≥5次/小时),3309人(25.7%)患有肥胖症(BMI≥30kg/m²)。IPD荟萃分析显示,31.5%[95%置信区间:16.8 - 48.5]的OSA患者患有肥胖症,44.4%[36.5 - 52.5]的患者超重(2

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13a5/12051718/e422570cfd85/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13a5/12051718/25c33b6eef3d/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13a5/12051718/3f7eb1c278f0/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13a5/12051718/58b324819c5d/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13a5/12051718/7023f87c72e5/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13a5/12051718/e422570cfd85/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13a5/12051718/25c33b6eef3d/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13a5/12051718/3f7eb1c278f0/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13a5/12051718/58b324819c5d/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13a5/12051718/7023f87c72e5/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13a5/12051718/e422570cfd85/gr5.jpg

相似文献

1
The relationship between obesity and obstructive sleep apnea in four community-based cohorts: an individual participant data meta-analysis of 12,860 adults.四个社区队列中肥胖与阻塞性睡眠呼吸暂停之间的关系:一项对12860名成年人的个体参与者数据荟萃分析
EClinicalMedicine. 2025 Apr 23;83:103221. doi: 10.1016/j.eclinm.2025.103221. eCollection 2025 May.
2
Polysomnography in patients with obstructive sleep apnea: an evidence-based analysis.阻塞性睡眠呼吸暂停患者的多导睡眠图:一项基于证据的分析。
Ont Health Technol Assess Ser. 2006;6(13):1-38. Epub 2006 Jun 1.
3
Increase in Body Mass Index Decreases Duration of Apneas and Hypopneas in Obstructive Sleep Apnea.体重指数增加可减少阻塞性睡眠呼吸暂停患者的呼吸暂停和低通气时间。
Respir Care. 2019 Jan;64(1):77-84. doi: 10.4187/respcare.06297.
4
Gender differences in severity of desaturation events following hypopnea and obstructive apnea events in adults during sleep.成人睡眠期间呼吸浅慢及阻塞性呼吸暂停事件后血氧饱和度降低事件严重程度的性别差异。
Physiol Meas. 2017 Jul 26;38(8):1490-1502. doi: 10.1088/1361-6579/aa7b6f.
5
Comparison of WatchPAT to polysomnography measurement of apnea-hypopnea index and obstructive sleep apnea severity in adolescents with overweight and obesity.在超重和肥胖青少年中,将WatchPAT与多导睡眠图测量的呼吸暂停低通气指数及阻塞性睡眠呼吸暂停严重程度进行比较。
J Clin Sleep Med. 2025 Apr 1;21(4):695-702. doi: 10.5664/jcsm.11530.
6
Obstructive sleep apnea in patients undergoing bariatric surgery--a tertiary center experience.肥胖症患者接受减重手术后的阻塞性睡眠呼吸暂停——一家三级中心的经验。
Obes Surg. 2011 Mar;21(3):316-27. doi: 10.1007/s11695-009-9928-1. Epub 2009 Aug 11.
7
Obstructive sleep apnea in children and adolescents with and without obesity.伴有和不伴有肥胖的儿童及青少年的阻塞性睡眠呼吸暂停
Eur Arch Otorhinolaryngol. 2019 Mar;276(3):871-878. doi: 10.1007/s00405-019-05290-2. Epub 2019 Jan 28.
8
Impact of obstructive sleep apnea on lung volumes and mechanical properties of the respiratory system in overweight and obese individuals.阻塞性睡眠呼吸暂停对超重和肥胖个体肺容量及呼吸系统力学特性的影响。
BMC Pulm Med. 2015 Jul 25;15:76. doi: 10.1186/s12890-015-0063-6.
9
Quality of life in children and adolescents with overweight or obesity: Impact of obstructive sleep apnea.超重或肥胖儿童和青少年的生活质量:阻塞性睡眠呼吸暂停的影响。
Int J Pediatr Otorhinolaryngol. 2020 Nov;138:110320. doi: 10.1016/j.ijporl.2020.110320. Epub 2020 Aug 18.
10
[Expert consensus on the diagnosis and treatment of obstructive sleep apnea in women].[女性阻塞性睡眠呼吸暂停诊断与治疗专家共识]
Zhonghua Jie He He Hu Xi Za Zhi. 2024 Jun 12;47(6):509-528. doi: 10.3760/cma.j.cn112147-20240206-00072.

引用本文的文献

1
The Potential Role of Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists and Glucose-Dependent Insulinotropic Polypeptide (GIP) Receptor Agonists in Obstructive Sleep Apnea and Obesity.胰高血糖素样肽-1(GLP-1)受体激动剂和葡萄糖依赖性促胰岛素多肽(GIP)受体激动剂在阻塞性睡眠呼吸暂停和肥胖中的潜在作用
Curr Pulmonol Rep. 2025;14(1):19. doi: 10.1007/s13665-025-00384-1. Epub 2025 Jul 25.

本文引用的文献

1
Association between weight-adjusted waist index and obstructive sleep apnea among adults in the United States: data from NHANES (2005-2008 and 2015-2018).美国成年人中体重调整腰围指数与阻塞性睡眠呼吸暂停之间的关联:来自美国国家健康与营养检查调查(2005 - 2008年和2015 - 2018年)的数据
J Int Med Res. 2025 Jan;53(1):3000605241311450. doi: 10.1177/03000605241311450.
2
Correlation between obstructive sleep apnea and weight-adjusted-waist index: a cross-sectional study.阻塞性睡眠呼吸暂停与体重校正腰围指数之间的相关性:一项横断面研究。
Front Med (Lausanne). 2024 Oct 23;11:1463184. doi: 10.3389/fmed.2024.1463184. eCollection 2024.
3
Obstructive sleep apnea and obesity: A review of epidemiology, pathophysiology and the effect of weight-loss treatments.
阻塞性睡眠呼吸暂停与肥胖:流行病学、病理生理学及减肥治疗效果的综述。
Sleep Med Rev. 2024 Dec;78:101996. doi: 10.1016/j.smrv.2024.101996. Epub 2024 Aug 30.
4
Effect of obesity on sleep apnea pathogenesis differs in women versus men: multiple mediation analyses in the retrospective SNOOzzzE cohort.肥胖对女性与男性睡眠呼吸暂停发病机制的影响不同:回顾性 SNOOzzzE 队列中的多重中介分析。
J Appl Physiol (1985). 2024 Jun 1;136(6):1516-1525. doi: 10.1152/japplphysiol.00925.2023. Epub 2024 Apr 25.
5
Tirzepatide for the treatment of obstructive sleep apnea: Rationale, design, and sample baseline characteristics of the SURMOUNT -OSA phase 3 trial.特立帕肽治疗阻塞性睡眠呼吸暂停:SURMOUNT-OSA 三期临床试验的原理、设计和样本基线特征。
Contemp Clin Trials. 2024 Jun;141:107516. doi: 10.1016/j.cct.2024.107516. Epub 2024 Mar 26.
6
Treatment of Sleep Apnea and Reduction in Blood Pressure: The Role of Heart Rate Response and Hypoxic Burden.治疗睡眠呼吸暂停和降低血压:心率反应和低氧负荷的作用。
Hypertension. 2024 May;81(5):1106-1114. doi: 10.1161/HYPERTENSIONAHA.123.22444. Epub 2024 Mar 20.
7
Association of adiposity with risk of obstructive sleep apnea: a population-based study.肥胖与阻塞性睡眠呼吸暂停风险的关联:一项基于人群的研究。
BMC Public Health. 2023 Sep 21;23(1):1835. doi: 10.1186/s12889-023-16695-4.
8
Hypoxic Burden Based on Automatically Identified Desaturations Is Associated with Adverse Health Outcomes.基于自动识别的血氧饱和度降低的缺氧负担与不良健康结局相关。
Ann Am Thorac Soc. 2023 Nov;20(11):1633-1641. doi: 10.1513/AnnalsATS.202303-248OC.
9
Pathophysiological mechanisms and therapeutic approaches in obstructive sleep apnea syndrome.阻塞性睡眠呼吸暂停综合征的病理生理机制和治疗方法。
Signal Transduct Target Ther. 2023 May 25;8(1):218. doi: 10.1038/s41392-023-01496-3.
10
Obstructive sleep apnoea heterogeneity and cardiovascular disease.阻塞性睡眠呼吸暂停异质性与心血管疾病。
Nat Rev Cardiol. 2023 Aug;20(8):560-573. doi: 10.1038/s41569-023-00846-6. Epub 2023 Mar 10.